Cancer combo trial pulled before it even started
NCT ID NCT07137390
First seen Jan 28, 2026 · Last updated Apr 24, 2026 · Updated 17 times
Summary
This study was designed to test a combination of two drugs (regorafenib and lorigerlimab) given before surgery to people with a certain type of colorectal cancer that had spread only to the lungs. The goal was to see if the treatment was safe and could help shrink tumors. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.